Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

NASDAQ:LGND   3:59:59 PM EDT
125.21
-5.32 (-4.08%)
Other Pre-Announcement

Ligand Forecasts 2021 Captisol Material Sales Of $200 Million

Published: 09/23/2020 12:54 GMT
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B (LGND) - Ligand Announces Its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million.
Ligand Pharmaceuticals Inc - Sees 2021 Captisol Material Sales of About $200 Million.